Medications for Covid19 Virus Disease

3 results
  • actemra - tocilizumab injection, solution, concentrate

    (Tocilizumab)
    Genentech, Inc.
    Actemra (tocilizumab) treats moderately to severely active rheumatoid arthritis, giant cell arteritis, SSc-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis (ages 2+), CAR T cell-induced cytokine release syndrome, and hospitalized COVID-19 patients requiring oxygen support or mechanical ventilation.
  • olumiant - baricitinib tablet, film coated

    (Baricitinib)
    Eli Lilly And Company
    Olumiant (baricitinib) treats adults with moderately-to-severely active rheumatoid arthritis after TNF blocker failure, hospitalized adults with COVID-19 requiring oxygen or mechanical ventilation, and adults with severe alopecia areata.
  • paxlovid - nirmatrelvir and ritonavir

    (Nirmatrelvir And Ritonavir)
    Pfizer Laboratories Div Pfizer Inc
    Paxlovid treats mild-to-moderate COVID-19 in adults at high risk of progression to severe illness, hospitalization, or death. Not approved for pre- or post-exposure COVID-19 prevention.